Announced Tue, 21 Jul · 20:25 IST
SME Listing Exemption From Corporate Governance Report Filing for Q1 FY26
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Chandra Bhagat Pharma has informed BSE that the Corporate Governance Report under SEBI LODR Regulations does not apply to the company for the quarter ended 30 June 2026, as it is listed on the SME Exchange and qualifies for exemption under Regulation 15. No governance report filing is required this quarter. This is a routine regulatory disclosure with no material business or financial impact.
Likely market impact
Routine procedural filing. No material impact on shareholders or stock price. Exemption applies because the company is listed on the SME platform.